Prescribing information and Adverse event reporting can be found at the bottom of the page

Brand Navigation Banner

Search Header

Making younger women aware of intrauterine contraception

Tailoring contraceptive choice, understanding the value of remote counselling and consultations and advice for offering Kyleena (19.5mg levonorgestrel)


    A year of coil activity in Leeds sexual health

    Author/Uploaded by

    By Dr Radhika Vohra, NHS and Private GP


    Learning objectives:

    • The contraceptive needs for younger patients
    • The effect of COVID-19 on contraception policy
    • What is Kyleena (19.5mg levonorgestrel) and when is it indicated?
    • Differences between Mirena (52mg levonorgestrel) and Kyleena (19.5mg levonorgestrel)
    • How to tackle common myths regarding IUDs
    • Factors affecting contraceptive choices in younger patients


    A tailored approach to contraception

      Watch now
    A year of coil activity in Leeds sexual health

    Dr Madeleine Crow, Specialist Registrar in Community Sexual and Reproductive Health

      Watch now
    A tailored approach to contraception

    Dr Farah Chaudhry, Consultant in Sexual and Reproductive Health in Leeds Community Healthcare NHS Trust

    Our speakers

    Latest videos

    Bayer IUS supporting women's reproductive lifecycle and beyond
    Watch now
    Menopause case 8 - Donna
    Watch now
    Developing an effective IUS/D service for 2021/2 and beyond
    Watch now

    RP-PF-WHC-GB-1286 May 2023 

    Search Footer

    Reporting adverse events and quality complaints


    Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Bayer plc.


    If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 011820‍63500 or email:


    Further information is available on the “contact” tab at